Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 12360153)

Published in Am Heart J on October 01, 2002

Authors

Jean-Claude Tardif1, Jean Grégoire, Jacques Lespérance, Jean Lambert, Philippe L L'Allier, Josep Rodés, Todd Anderson, John W Blue, James Imus, Therese Heinonen

Author Affiliations

1: Montreal Heart Institute, Montreal, Quebec, Canada. tardifjc@icm.umontreal.ca

Articles by these authors

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med (2011) 15.30

Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17

2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol (2013) 5.97

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol (2009) 5.65

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA (2007) 3.12

Comparison of gas exchange data using the Aquatrainer system and the facemask with Cosmed K4b2 during exercise in healthy subjects. Eur J Appl Physiol (2010) 2.73

The assessment of endothelial function: from research into clinical practice. Circulation (2012) 2.68

Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol (2003) 2.48

Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J Am Coll Cardiol (2005) 2.14

Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation (2007) 1.88

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial. Eur Heart J (2014) 1.88

Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol (2013) 1.70

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 1.69

Early negative T waves and viable myocardium in patients with a first ST-elevation acute coronary syndrome. J Electrocardiol (2005) 1.68

Statin in combination with β-blocker therapy reduces postoperative stroke after coronary artery bypass graft surgery. Ann Thorac Surg (2011) 1.56

Quantitative hyperemic reactivity in opposed limbs during myocardial perfusion imaging: a new marker of coronary artery disease. J Am Coll Cardiol (2004) 1.53

Intensive rehabilitation combined with HBO2 therapy in children with cerebral palsy: a controlled longitudinal study. Undersea Hyperb Med (2014) 1.47

Comparison of left ventricular contraction homogeneity index using SPECT gated blood pool imaging and planar phase analysis. J Nucl Cardiol (2007) 1.47

Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. Am J Gastroenterol (2003) 1.46

Importance of collateral circulation in coronary heart disease. Eur Heart J (2007) 1.45

Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesth Analg (2003) 1.45

Reducing the growth of Medicare spending: geographic versus patient-based strategies. Health Aff (Millwood) (2004) 1.45

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation (2004) 1.45

Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. J Thorac Cardiovasc Surg (2007) 1.44

The utility of base deficit and arterial lactate in differentiating major from minor injury in trauma patients with normal vital signs. Resuscitation (2008) 1.43

Two-year angiographic follow-up of intracoronary Sr90 therapy for restenosis prevention after balloon angioplasty. Circulation (2002) 1.42

Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study. Circulation (2004) 1.42

Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation (2003) 1.38

Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol (2004) 1.32

Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol (2003) 1.29

Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry (2007) 1.21

Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol (2003) 1.16

Expedited transfer for primary percutaneous coronary intervention: a program evaluation. CMAJ (2007) 1.13

Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br J Pharmacol (2005) 1.11

Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol (2013) 1.10

Vascular biomarkers and surrogates in cardiovascular disease. Circulation (2006) 1.09

Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation (2003) 1.09

Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement. Can J Cardiol (2009) 1.04

Psychological distress among female spouses of male at-risk drinkers. Alcohol (2006) 1.02

Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations. Am J Cardiol (2005) 1.00

Manganese concentrations in the air of the Montreal (Canada) subway in relation to surface automobile traffic density. Sci Total Environ (2005) 0.98

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol (2002) 0.98

Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse. Blood Press Monit (2005) 0.97

Right ventricular myocardial performance index predicts perioperative mortality or circulatory failure in high-risk valvular surgery. J Am Soc Echocardiogr (2007) 0.93

Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab (2010) 0.93

Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: implications for myocardial perfusion imaging. J Am Coll Cardiol (2005) 0.92

High-density lipoprotein/apolipoprotein A-I infusion therapy. Curr Atheroscler Rep (2009) 0.91

Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metab (2010) 0.91

Perchlorate in wet deposition across North America. Environ Sci Technol (2009) 0.90

A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Circ Cardiovasc Interv (2010) 0.90

Value of sentinel node mapping in cancer of the cervix. Gynecol Oncol (2011) 0.90

Prevention of restenosis with antioxidants: mechanisms and implications. Am J Cardiovasc Drugs (2002) 0.89

Effects of the nitric oxide synthase inhibitor L-NMMA on cerebrovascular and cardiovascular responses to hypoxia and hypercapnia in humans. J Physiol (2007) 0.88

A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen Psychiatry (2012) 0.88

Treatment preferences in patients with first episode depression. J Affect Disord (2012) 0.88

Pulmonary hypertension in cardiac surgery. Curr Cardiol Rev (2010) 0.87

Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag (2006) 0.86

Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg (2007) 0.86

One core laboratory at two international sites, is that feasible? An inter-core laboratory and intra-observer variability study. Catheter Cardiovasc Interv (2002) 0.86

Catechin prevents severe dyslipidemia-associated changes in wall biomechanics of cerebral arteries in LDLr-/-:hApoB+/+ mice and improves cerebral blood flow. Am J Physiol Heart Circ Physiol (2012) 0.85

Long-term outcomes after the atrial switch for surgical correction of transposition: a meta-analysis comparing the Mustard and Senning procedures. Cardiol Young (2004) 0.85

Preliminary experience in the use of preoperative echo-guided left stellate ganglion block in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth (2010) 0.85

Cerebral Oximetry Monitoring to Maintain Normal Cerebral Oxygen Saturation during High-risk Cardiac Surgery: A Randomized Controlled Feasibility Trial. Anesthesiology (2016) 0.84

Perchlorate in fish from a contaminated site in east-central Texas. Environ Pollut (2005) 0.84

Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre. Can J Cardiol (2006) 0.83

Coronary vasodilator reserve and Framingham risk scores in subjects at risk for coronary artery disease. J Nucl Cardiol (2006) 0.83

Bioaccumulation and locomotor effects of manganese sulfate in Sprague-Dawley rats following subchronic (90 days) inhalation exposure. Toxicol Appl Pharmacol (2005) 0.83

Inequities in medical follow-up for depression: a population-based study in Montreal. Psychiatr Serv (2010) 0.83

Economic impact of contrast stress echocardiography on the diagnosis and initial treatment of patients with suspected coronary artery disease. J Am Soc Echocardiogr (2002) 0.83

Neuropsychological effects of hyperbaric oxygen therapy in cerebral palsy. Dev Med Child Neurol (2002) 0.83

Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease. Coron Artery Dis (2003) 0.83

Large and small vessel vasoconstriction following coronary artery stenting. Effect of intra coronary nitroglycerine and relation to LDL cholesterol. Int J Cardiol (2005) 0.83

Effects of the antioxidant succinobucol (AGI-1067) on human atherosclerosis in a randomized clinical trial. Atherosclerosis (2007) 0.83

Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease. Am Heart J (2010) 0.82

A single bout of high-intensity interval exercise does not increase endothelial or platelet microparticles in stable, physically fit men with coronary heart disease. Can J Cardiol (2013) 0.82

Effect of atherosclerotic regression on total luminal size of coronary arteries as determined by intravascular ultrasound. Am J Cardiol (2006) 0.82

Interexaminer reliability of Amiel-Tison neurological assessments. Pediatr Neurol (2009) 0.82

Primitive clear cell carcinoma of the vagina treated conservatively. J Obstet Gynaecol Can (2009) 0.81

Human epididymis protein 4 (HE4) and ovarian cancer prognosis. Gynecol Oncol (2012) 0.81